Large-scale testing (Phase 3)Ended earlyNCT01103362
What this trial is testing
A 28-week Safety Study of Flibanserin in Pre- and Postmenopausal Women With Hypoactive Sexual Desire Disorder
Who this might be right for
Sexual Dysfunctions, Psychological
Sprout Pharmaceuticals, Inc 596